Search
Search Results
##search.searchResults.foundPlural##
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2580PDF: 798HTML: 5214 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3771PDF: 1661HTML: 11590Figures Haase: 198 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1676PDF: 806HTML: 936cover letter: 267 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3236PDF: 1334HTML: 4129 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3935PDF: 1492HTML: 9188Untitled: 277Untitled: 183Untitled: 168Untitled: 164Untitled: 180Untitled: 338 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
477PDF: 243HTML: 78 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2069PDF: 1114HTML: 7693cover letter paper final AML: 214 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1042PDF: 1154Suppl. Files: 569HTML: 88 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1782PDF: 966HTML: 143 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1755PDF: 570HTML: 282 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1349PDF: 820HTML: 5036INSTITUTE PUBLICATION COMMITTEE APPROVAL: 161 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1523PDF: 538HTML: 272 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3510PDF: 881HTML: 1653figure 1: 165Untitled: 188 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2452PDF: 784HTML: 1735 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2193PDF: 797HTML: 1627Figure 1: 182Table 1: 205 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1611PDF: 806HTML: 165 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1957PDF: 711HTML: 683Table1: patient's characteristics: 155Table 2: profile of each patient: 178 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2686PDF: 764HTML: 219 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4316PDF: 1763HTML: 1106 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1457PDF: 761Suppl. Files: 323Html: 135 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2258PDF: 836HTML: 2137New table Chinese children with APL: 160 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3883PDF: 755HTML: 1849 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1994PDF: 1130HTML: 625 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1309PDF: 1200HTML: 447 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1488PDF: 768HTML: 203 -
Osteolytic bone lesions – A rare presentation of AML M6.
1971PDF: 1095HTML: 7936Untitled: 203 -







